Microbio Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
May 11, 2022
Share
Microbio Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was TWD 394.15 million compared to TWD 384.83 million a year ago. Revenue was TWD 402.02 million compared to TWD 392.63 million a year ago. Net income was TWD 807.24 million compared to TWD 464.34 million a year ago. Basic earnings per share from continuing operations was TWD 1.5876 compared to TWD 0.9398 a year ago. Diluted earnings per share from continuing operations was TWD 1.5785 compared to TWD 0.9398 a year ago.
Microbio Co., Ltd. is a Taiwan-based company primarily engaged in the research, development, manufacture, distribution and wholesales of healthcare food products and pharmaceuticals. The Company provides fermentation products, including Tien Chun Bao (TCB) oral solutions; herbal products, including LeeHerb series products, as well as organic foods, including vegetables, fruits, nuts, pastry, seasonings, organic meals and others. In addition, it provides new medicines, including anticancer medicines, medicines for hepatitis, allergy, rheumatoid arthritis and others. The Company mainly distributes its products mainly within domestic market.
MICROBIO CO., LTD. 
